OBJECTIVE AND DESIGN: Increasing evidence supports a parallel between HIV-1 infection and immune aging, which is particularly apparent with common changes in naive versus memory T-cell proportions. Here, we aimed at refining the value of common T-cell-associated markers of immunosenescence during HIV disease progression or aging, and at exploring further the impact in this context of old age as well as cytomegalovirus (CMV) co-infection, which is predominant in HIV-1-infected individuals. METHODS: Frequencies of naive or CD57(+) memory T cells as well as the magnitude of CMV-pp65 T cells were measured in HIV-1-infected patients grouped according to disease progression status, treatment and age. RESULTS: Our results indicate that the decline in naive T-cell levels rather than the accumulation of CD57(+) senescent T cells identifies best the premature development of an immunosenescence phenotype with HIV disease progression. Moreover, advanced age or mounting of strong CMV-specific responses impact independently on CD4(+) T-cell counts and recovery with antiretroviral therapy. CONCLUSIONS: The present findings indicate that HIV-1 infection amplifies the effect of age on naive T-cell levels, and highlight the constraint on the capacity of treated patients to reconstitute their CD4(+) T-cell compartment due to age and CMV co-infection.
OBJECTIVE AND DESIGN: Increasing evidence supports a parallel between HIV-1 infection and immune aging, which is particularly apparent with common changes in naive versus memory T-cell proportions. Here, we aimed at refining the value of common T-cell-associated markers of immunosenescence during HIV disease progression or aging, and at exploring further the impact in this context of old age as well as cytomegalovirus (CMV) co-infection, which is predominant in HIV-1-infected individuals. METHODS: Frequencies of naive or CD57(+) memory T cells as well as the magnitude of CMV-pp65 T cells were measured in HIV-1-infectedpatients grouped according to disease progression status, treatment and age. RESULTS: Our results indicate that the decline in naive T-cell levels rather than the accumulation of CD57(+) senescent T cells identifies best the premature development of an immunosenescence phenotype with HIV disease progression. Moreover, advanced age or mounting of strong CMV-specific responses impact independently on CD4(+) T-cell counts and recovery with antiretroviral therapy. CONCLUSIONS: The present findings indicate that HIV-1 infection amplifies the effect of age on naive T-cell levels, and highlight the constraint on the capacity of treated patients to reconstitute their CD4(+) T-cell compartment due to age and CMV co-infection.
Authors: H Lim; L Kane; J B Schwartz; C S Hesdorffer; S G Deeks; N Greig; L Ferrucci; E J Goetzl Journal: Clin Exp Immunol Date: 2012-08 Impact factor: 4.330
Authors: Karim Sacre; Peter W Hunt; Priscilla Y Hsue; Ekaterina Maidji; Jeffrey N Martin; Steven G Deeks; Brigitte Autran; Joseph M McCune Journal: AIDS Date: 2012-04-24 Impact factor: 4.177
Authors: Kristine M Erlandson; Amanda A Allshouse; Eric Rapaport; Brent E Palmer; Cara C Wilson; Adriana Weinberg; Samantha MaWhinney; Thomas B Campbell Journal: AIDS Res Hum Retroviruses Date: 2015-07-08 Impact factor: 2.205
Authors: Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin Journal: AIDS Date: 2013-05-15 Impact factor: 4.177
Authors: Nicholas T Funderburg; David A Zidar; Carey Shive; Anthony Lioi; Joseph Mudd; Laura W Musselwhite; Daniel I Simon; Marco A Costa; Benigno Rodriguez; Scott F Sieg; Michael M Lederman Journal: Blood Date: 2012-10-11 Impact factor: 22.113